Tags Archive Navigation
icon
-
Featured NewsNovartis receives FDA fast track designation for LNA043 in osteoarthritis of the knee
-
Featured NewsNovartis announces discontinuation of CIRRUS-1 study of CFZ533 (iscalimab) in kidney transplant patients
-
Featured NewsMeet Novartis Management 2020
-
Featured NewsAI Nurse set to transform standards of care for heart failure patients in China
-
Featured NewsImpact Measurement and Valuation
-
Featured NewsNovartis research shows technology talent increasingly drawn to pharma industry since COVID-19
-
Featured NewsWorld Malaria Day 2020
-
Featured NewsEuropean Patient Innovation Summit publishes call for action to ensure greater patient involvement in digital health solution development
-
Featured NewsLife Science Companies and the Bill & Melinda Gates Foundation: Joint Communique
-
Featured NewsNovartis 2016 Financial Results
-
Featured NewsThe Co-Creating Impact Summit for the society and the planet
-
Featured NewsNovartis Financial Results – Q2 2018
Pagination
- ‹ Previous page
- 1
- …
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- …
- 15
- › Next page